IL15 and rheumatoid arthritis: In addition, in CHIP carriers, pathways such as IL-15 signaling, B cell receptor signaling, lupus in B cells signaling, and rheumatoid arthritis pathways were dysregulated in comparison to control (Fig. 3b, right panel).